16 completed. 16 Phase 2, 3 Phase 1, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 16 | Completed 16 |
| Phase 1 | 3 | Completed 3 |
| Phase 3 | 2 | Completed 2 |
Follow Critically Ill: new trials by email Literature Review of Critically Ill trials Research Report on Critically Ill
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Rapid Pathogen Detection in ICU Patients With Suspected Pneumonia on Antimicrobial Therapy FA Pneumonia Panel - Pneumonia, Critically Ill | Phase 2 | Completed | Chinese University of Hong Kong | 40 | 2024-06-26 | 2026-03-06 |
| Fludrocortisone Dose Response Relationship in Septic Shock - FluDReSS Fludrocortisone Acetate, Standard Therapy - Critically Ill, Septic Shock | Phase 2 | Completed | The George Institute | 155 | 2021-02-11 | 2024-01-18 |
| Comparison of Biphozyl® and Phoxilium® as a Replacement Fluid During CVVH for AKI in Adults and Their Effects on pH-, Bicarbonate-levels and Respiratory Situation CVVH with Phoxilium® in the first 48h after randomization, CVVH with Biphozyl® in the first 48h after randomization, CVVH with Phoxilium® in the second 48h after randomization (after previous 48h with Biphozyl®) - Critically Ill, Acute Kidney Injury | Phase 2 | Completed | Medical University Innsbruck | 88 | 2020-08-01 | 2024-03-13 |
| Coated Devices to Decrease Infection in the Intensive Care Unit Coated devices, Control - Critically Ill | Phase 1 / Phase 2 | Completed | Hospital do Coracao | 103 | 2019-04-06 | 2020-03-09 |
| Intensive Nutrition in Critically Ill Adults Supplemental parenteral nutrition - Critical Illness, Critically Ill | Phase 2 | Completed | Australian and New Zealand Intensive Care Research Centre | 240 | 2018-10-15 | 2024-05-24 |
| The Vitamin C, Hydrocortisone and Thiamine in Patients With Septic Shock Trial Vitamin C, Thiamine, Hydrocortisone, - Shock, Septic, Critically Ill | Phase 2 | Completed | Australian and New Zealand Intensive Care Research Centre | 216 | 2018-05-02 | 2019-10-10 |
| Activated Vitamin D for the Prevention and Treatment of Acute Kidney Injury Calcifediol, Calcitriol, Placebos - Critically Ill, Acute Kidney Injury | Phase 2 | Completed | David Leaf | 150 | 2017-04-03 | 2025-09-29 |
| Promotion of Oesophageal Motility to Prevent Regurgitation and Enhance Nutrition Intake in ICU Patients. E-Motion System, Sham E-Motion System - Critically Ill, Malnutrition | Phase 2 | Completed | E-Motion Medical Ltd. | 158 | 2016-02-01 | 2019-07-10 |
| Screening Elderly Patients for Weaning Once daily screening, At least twice daily screening - Critically Ill | Phase 2 | Completed | Unity Health Toronto | 102 | 2015-01-01 | 2017-10-20 |
| Prevention of Nosocomial Infections in Critically Ill Patients With Lactoferrin: The PREVAIL Study Lactoferrin, Placebo - Critically Ill | Phase 2 | Completed | Queen's University | 214 | 2013-11-01 | 2017-02-20 |
| The Effect of Thiamine vs. Placebo on VO2 in Critical Illness Thiamine - Critically Ill, Respiratory Failure | Phase 2 | Completed | Beth Israel Deaconess Medical Center | 66 | 2013-10-01 | 2017-10-02 |
| TEAM: A Trial of Early Activity and Mobility in ICU Early mobilisation - Critically Ill | Phase 1 / Phase 2 | Completed | Australian and New Zealand Intensive Care Research Centre | 50 | 2013-08-01 | 2018-08-22 |
| The Use of Methadone in Newborn Infants Methadone - Premature Birth of Newborn, Critically Ill | Phase 1 / Phase 2 | Completed | John van den Anker | 60 | 2010-12-01 | 2018-07-26 |
| Family Preparation Study For Withdrawal of Mechanical Ventilation From Their Family Member family preparation for withdrawing life support - Mechanical Ventilation, Critically Ill | Phase 2 | Completed | University of Wisconsin, Madison | 20 | 2003-10-01 | 2015-10-05 |
| N-Acetylcysteine in Critically Ill Patients Undergoing Contrast Enhanced Computed Tomography N-acetylcysteine, D5W Placebo - Contrast Induced Nephropathy, Critically Ill | Phase 2 / Phase 3 | Completed | Unity Health Toronto | 45 | 2002-08-01 | 2009-01-27 |
| Heparin Binding Protein in Patients With Acute Respiratory Failure Treated With GCSF (Filgrastim) Filgrastim - Acute Respiratory Failure, Critically Ill | Phase 2 / Phase 3 | Completed | Helsinki University Central Hospital | 59 | 1996-01-01 | 2012-10-29 |
Critical Illness (16) · Acute Kidney Injury (2) · Sepsis (2) · Shock, Septic (2) · Hyperphagia (1) · Infections (1) · Malnutrition (1) · Pneumonia (1) · Pneumonia, Ventilator-Associated (1) · Premature Birth (1) · Respiratory Insufficiency (1) · Vasoplegia (1)
Disease Attributes (16) · Pathologic Processes (16) · Pathological Conditions, Signs and Symptoms (16) · Female Urogenital Diseases and Pregnancy Complications (3) · Infections (3) · Inflammation (3) · Respiratory Tract Diseases (3) · Systemic Inflammatory Response Syndrome (3) · Urogenital Diseases (3) · Female Urogenital Diseases (2) · Kidney Diseases (2) · Lung Diseases (2) · Male Urogenital Diseases (2) · Renal Insufficiency (2) · Respiratory Tract Infections (2)
Thiamine (2) · Acetylcysteine (1) · Ascorbic Acid (1) · Calcifediol (1) · Calcitriol (1) · Filgrastim (1) · Hydrocortisone (1) · Inulin (1) · Lactoferrin (1) · Methadone (1) · Rehabilitation (1) · Standard of Care (1) · fludrocortisone acetate (1) · sinistrin (1)
Australian and New Zealand Intensive Care Research Centre (3) · Unity Health Toronto (2) · Beth Israel Deaconess Medical Center (1) · Chinese University of Hong Kong (1) · David Leaf (1) · E-Motion Medical Ltd. (1) · Helsinki University Central Hospital (1) · Hospital do Coracao (1) · John van den Anker (1) · Medical University Innsbruck (1) · Queen's University (1) · The George Institute (1) · University of Wisconsin, Madison (1)
Australia (4) · Canada (4) · United States (4) · New Zealand (3) · Brazil (2) · Austria (1) · Finland (1) · Hong Kong (1)
Alexandre Biasi, MD/PhD (1) · Carol L Hodgson, PhD (1) · Claudio M Martin, MD, FRCPC, MSc (1) · Daren K Heyland, MD (1) · David E Leaf, MD, MMSc (1) · Emma Ridley, PhD (1) · James Walsham, MB ChB, MRCP, FCICM. (1) · John G Muscedere, MD (1) · Karen E. A. Burns, MD, FRCPC (1) · Karin T Kirchhoff (1) · Katherine Berg, MD (1) · Kirsi-Maija Kaukonen, MD, PhD (1) · Michael Joannidis, Univ.-Prof., MD (1) · Nora Luethi, MD (1) · Rinaldo Bellomo, Professor (1)
PMID 11098963, PMID 15883741, PMID 23363492, PMID 29924393, PMID 30805946, PMID 30920411, PMID 31142242, PMID 31950979, PMID 32526149, PMID 33315720, PMID 35260448, PMID 39235623, PMID 39762887, PMID 40759107, PMID 40924491, PMID 41247497
K23DK106448 (1)